𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy

✍ Scribed by Sculier, J.P.; Weerts, D.; Klastersky, J.

Book ID
122426347
Publisher
Elsevier Science
Year
1984
Weight
577 KB
Volume
20
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

DoubleΞ²-lactam regimen compared to an am
DoubleΞ²-lactam regimen compared to an aminoglycoside/Ξ²-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
✍ Jai H. Joshi; Kathryn A. Newman; Bary W. Brown; Rebecca S. Finley; Robert L. Rux πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 824 KB

In a prospective, randomized trial, 205 febrile episodes in granulocytopenic cancer patients were treated with ceftazidime with or without tobramycin (C +/- T), both agents being administered only if the initial granulocyte count was below 200/microliters, or ceftazidime plus piperacillin (C + P). T

Ceftazidime and amikacin as empiric anti
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes
✍ G. Todeschini; D. Veneri; S. Carlini; G. Pizzolo; A. Ambrosetti; R. Bonesi; V. C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 695 KB

One hundred and seventy-one consecutive febrile episodes occurring in 130 neutropenic adult patients with hematological malignancies (mainly acute leukemia) were empirically treated with a combination antibiotic therapy consisting of ceftazidime (100 mg/kg/day) + amikacin (1 5 mg/kg/day). Of these,